Identification of Polo-like kinase 1 as a potential therapeutic target in anaplastic thyroid carcinoma. (Articolo in rivista)

Type
Label
  • Identification of Polo-like kinase 1 as a potential therapeutic target in anaplastic thyroid carcinoma. (Articolo in rivista) (literal)
Anno
  • 2009-01-01T00:00:00+01:00 (literal)
Http://www.cnr.it/ontology/cnr/pubblicazioni.owl#doi
  • 10.1158/0008-5472.CAN-08-1693 (literal)
Alternative label
  • Nappi TC; Salerno P; Zitzelsberger H; Carlomagno F; Salvatore G; Santoro M. (2009)
    Identification of Polo-like kinase 1 as a potential therapeutic target in anaplastic thyroid carcinoma.
    in Cancer research (Chic. Ill.)
    (literal)
Http://www.cnr.it/ontology/cnr/pubblicazioni.owl#autori
  • Nappi TC; Salerno P; Zitzelsberger H; Carlomagno F; Salvatore G; Santoro M. (literal)
Pagina inizio
  • 1916 (literal)
Pagina fine
  • 1923 (literal)
Http://www.cnr.it/ontology/cnr/pubblicazioni.owl#numeroVolume
  • 69 (literal)
Rivista
Http://www.cnr.it/ontology/cnr/pubblicazioni.owl#pagineTotali
  • 8 (literal)
Http://www.cnr.it/ontology/cnr/pubblicazioni.owl#numeroFascicolo
  • 5 (literal)
Note
  • ISI Web of Science (WOS) (literal)
Http://www.cnr.it/ontology/cnr/pubblicazioni.owl#affiliazioni
  • Dipartimento di Biologia e Patologia Cellulare e Molecolare ''L. Califano'' c/o Istituto di Endocrinologia ed Oncologia Sperimentale del CNR, Universita' ''Federico II''; Dipartimento di Studi delle Istituzioni e dei Sistemi Territoriali, Universita' ''Parthenope,'' Naples, Italy and Institute of Molecular Radiobiology, GSF-Forschungszentrum fu¨r Umwelt und Gesundheit GmbH, Neuherberg, Germany (literal)
Titolo
  • Identification of Polo-like kinase 1 as a potential therapeutic target in anaplastic thyroid carcinoma. (literal)
Abstract
  • Anaplastic thyroid carcinoma (ATC) is one of the most aggressive and chemoresistant cancers. The serine/threonine kinase Polo-like kinase 1 (PLK1),a key regulator of multiple steps during mitotic progression,is highly expressed in ATC. Here,we used the BI 2536 PLK1 inhibitor on ATC and nontransformed thyroid follicular cell lines. Our data show that ATC cells are addicted to high levels of PLK1 activity for proliferation,sur vival,anchorage-independent growth,and tumorigenicity. On treatment with nanomolar doses of BI 2536,ATC cells progressed normally through S phase but died thereafter,directly from mitotic arrest. Immunofluorescence microscopy,immunoblot,and flow cytometry analysis showed that,on PLK1 blockade, ATC cells arrested in prometaphase with a 4N DNA content. Treated ATC cells accumulated phosphohistone H3 and displayed characteristic mitotic (Polo) spindle aberrations. Nontransformed thyroid cells were 3.2- to 18.4-fold less susceptible to BI 2536-induced cell cycle effects compared with ATC cells. These findings identify PLK1 as a promising target for the molecular therapy of ATC. (literal)
Prodotto di
Autore CNR
Insieme di parole chiave

Incoming links:


Prodotto
Autore CNR di
Http://www.cnr.it/ontology/cnr/pubblicazioni.owl#rivistaDi
Insieme di parole chiave di
data.CNR.it